Alexandra M. Poos

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myeloma.

Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myeloma.

Journal: Leukemia
Published: August 01, 2025

Genomic features do not account for differences in multiple myeloma risk by ancestry.

Genomic features do not account for differences in multiple myeloma risk by ancestry.

Journal: Blood cancer discovery
Published: July 15, 2025

Bone marrow breakout lesions act as key sites for tumor-immune cell diversification in multiple myeloma.

Bone marrow breakout lesions act as key sites for tumor-immune cell diversification in multiple myeloma.

Journal: Science immunology
Published: February 07, 2025

Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma.

Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma.

Journal: Blood
Published: December 16, 2024

Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies.

Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies.

Journal: bioRxiv : the preprint server for biology
Published: November 28, 2024

Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies.

Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies.

Journal: Blood cancer discovery
Published: November 25, 2024

Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple Myeloma.

Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple Myeloma.

Journal: bioRxiv : the preprint server for biology
Published: September 16, 2024

The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma.

The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma.

Journal: Blood
Published: February 13, 2024

Temporal genomic dynamics shape clinical trajectory in multiple myeloma.

Temporal genomic dynamics shape clinical trajectory in multiple myeloma.

Journal: Nature genetics
Published: January 29, 2024

Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myeloma.

Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myeloma.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: January 11, 2024

Genomic Classification and Individualized Prognosis in Multiple Myeloma.

Genomic Classification and Individualized Prognosis in Multiple Myeloma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 09, 2024

The landscape of small nucleolar RNA expression in multiple myeloma is determined by cytogenetic alterations.

The landscape of small nucleolar RNA expression in multiple myeloma is determined by cytogenetic alterations.

Journal: Leukemia
Published: May 05, 2023
Showing 1-12 of 29

Last Updated: 09/26/2026